APP and Alzheimer disease: Additionally, McClean et al. (2014) investigated the role of liraglutide in APP/PS1 mice, a model of AD, and they reported that liraglutide improves cognitive function, decreases inflammation, decreases amyloid plaque deposition, and increases synapse numbers in the hippocampus [103].